Zenflow Spring System展示了扩大前列腺的长期效益,确保了31.4M美元的资金。 Zenflow Spring System shows lasting benefits for enlarged prostate, securing $31.4M in funding.

Zenflow, Inc.在其Zenflow Spring System(一种对扩大的前列腺的新的最低侵入性治疗,即BPH)中显示了积极的长期效果。 Zenflow, Inc. has shown positive long-term results for its Zenflow Spring System, a new minimally invasive treatment for enlarged prostate, or BPH. 在美国泌尿协会会议上提供的三年期数据显示,症状持续下降,性功能没有下降。 The three-year data presented at the American Urological Association meeting shows consistent symptom reduction and no decline in sexual function. 该公司获得了3 140万美元的资金,用于推进临床试验,为林业发展局批准和商业化做准备。 The company secured $31.4 million in funding to advance clinical trials and prepare for FDA approval and commercialization.